-
HATU: From Coupling Chemistry to Assay Design
2026-08-23
HATU enables controlled carboxylic acid activation for efficient amide and ester formation. This guide connects peptide coupling chemistry with the assay decisions required to evaluate selective aminopeptidase inhibitor analogues.
-
Dual TLR2/4 Inhibition in Oxygen-Induced Retinopathy
2026-08-22
Dayoub and colleagues identified AVR-121 and AVR-123 as dual TLR2/4 inhibitors that reduced inflammatory signaling and pathological angiogenesis in cellular assays and a mouse model of oxygen-induced retinopathy. The study is notable because AVR-123 was effective during both vaso-obliterative and neovascular phases, while preserving the VEGF response needed for normal juvenile retinal development.
-
CA-074 Me: Reading Lysosomal Death Signals
2026-08-21
CA-074 Me is a membrane-permeable cathepsin B inhibitor for distinguishing lysosomal membrane permeabilization from downstream cell rupture. This article translates mechanistic necroptosis findings into assay-design decisions, including controls for cathepsin L inhibition under reducing conditions.
-
PP 1: Src Family Tyrosine Kinase Inhibitor
2026-08-21
PP 1 is a Src family tyrosine kinase inhibitor with reported nanomolar activity against Lck and Fyn. Its research value spans Src-family signaling, T cell activation modulation, and RET oncogene inhibition, but it should not be treated as evidence of clinical cancer efficacy or as a direct proxy for Csk inhibition.
-
Ribotoxic Stress, ZAK, and UV-Induced Cell Death
2026-08-20
Sinha et al. show that UV-induced apoptosis is governed primarily by ribotoxic stress signaling through ZAK rather than by the canonical DNA damage response. Their time-resolved, multi-method framework reveals how GCN2 and ZAK degradation tune ribosome-collision signals between adaptation, tolerance, and cell death.
-
Sulfachloropyridazine and Cecal Microbiota in Coccidiosis
2026-08-20
The reference study used integrated 16S rRNA sequencing and LC-MS/MS metabolomics to examine how ethanamizuril, Sulfachloropyridazine, and their combination affect chickens infected with Eimeria tenella. Its main contribution is to connect anticoccidial treatment with drug-specific changes in cecal microbial composition and metabolite profiles, while showing that low-dose combination therapy produced limited additional disruption.
-
ω-Agatoxin IVA TFA: Cav2.1 Research Workflows
2026-08-19
ω-Agatoxin IVA TFA enables channel-resolved neuronal calcium current recording and synaptic transmission research by selectively targeting Cav2.1 rather than L- or T-type channels. Its strongest use is mechanistic separation: researchers can test presynaptic calcium entry, neurotransmitter release, seizure phenotypes, and neuroprotection without assuming that reduced release automatically prevents neuronal injury.
-
Trelagliptin Succinate: From Target to Assay
2026-08-19
Trelagliptin succinate is examined from DPP-4 enzyme inhibition through adipocyte insulin signaling, with emphasis on selecting assays that distinguish target engagement from downstream metabolic effects. This evidence-led guide also defines practical concentration, controls, and cross-domain interpretation limits for diabetes mellitus research.
-
Brefeldin A: A Causal Probe of ER Stress
2026-08-18
Brefeldin A is more than a vesicle transport inhibitor: it is a causal tool for connecting ER–Golgi disruption with proteostasis failure and cell fate. This guide integrates BFA mechanism, ER-stress biology, cancer assays, and evidence-based experimental design.
-
Ciprofloxacin Hydrochloride: Smarter Assays
2026-08-18
Ciprofloxacin hydrochloride is more than a fluoroquinolone antibiotic: it is a precise perturbation tool for studying DNA damage, bacterial survival, and context-dependent drug interactions. This guide translates single-cell findings into practical assay-design decisions while defining the limits of immunomodulatory and translational interpretation.
-
Hydroxychloroquine Sulfate Workflow Guide
2026-08-17
Hydroxychloroquine Sulfate (SKU B4874) provides a water-compatible research tool for examining autophagy pathway modulation and TLR7/9-dependent immune signaling. It is suited to short-term aqueous cell and animal workflows, but should not be selected for protocols requiring DMSO or ethanol solubility or long-term solution storage.
-
Ertapenem Sodium Salt for Resistance Workflows
2026-08-16
Build a reproducible ertapenem workflow that connects broth microdilution with carbapenemase detection, plasmid localization, and transmission analysis. This research-focused approach turns a broad-spectrum phenotype into actionable evidence for antibiotic resistance research.
-
Methoxy-X04: From Plaques to Translational Insight
2026-08-15
Methoxy-X04 offers more than plaque visualization: it can help translational teams connect amyloid burden with microglial clearance, exercise biology, and intervention response. This article integrates recent evidence on skeletal muscle-derived extracellular vesicles with practical imaging strategy for Alzheimer’s disease research.
-
Eltanexor Rewires Wnt Signaling in Colorectal Cancer
2026-08-15
A bioRxiv preprint reports that XPO1 inhibition with Eltanexor (KPT-8602) suppresses colorectal cancer-associated Wnt/β-catenin activity, reduces COX-2 expression, and limits tumor formation in Apcmin/+ mice. The study connects nuclear export control with a chemoprevention-relevant signaling axis and provides a preclinical framework for evaluating XPO1 inhibition in genetically predisposed colorectal cancer models.
-
CD28–ARS2–PKM Splicing in CD8+ T Cells
2026-08-14
The reference study identifies a CD28–ARS2 signaling axis that reshapes PKM alternative splicing and enables metabolic flexibility in activated CD8+ T cells. Its findings connect exon selection, glucose utilization, interferon-γ production, and antitumor activity while separating this mechanism from canonical CD28–PI3K signaling.
451 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page